መነሻ › የጡንቻ ካንሰር › ካሊፎርኒያ › San Diego
በSan Diego፣ CA ለየጡንቻ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች
ለየጡንቻ ካንሰር የሚደረጉ 41 ጥናቶች በSan Diego እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።
Official study text (English)
ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of California San Diego Moores Cancer Center, San Diego
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Sharp Rees Stealy Medical Group Inc, San Diego
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of California San Diego Moores Cancer Center, San Diego
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Sharp Memorial Hospital, San Diego
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- California Protons Cancer Therapy Center, San Diego
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
ተሳታዮችን በመፈለግ ላይደረጃ 3
- California Protons Cancer Therapy Center, San Diego
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- UC San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Clinical Trial Site, La Jolla · 11 ማይል ርቀት
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Moores Cancer Center, La Jolla · 11 ማይል ርቀት
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
- University of California San Diego, San Diego
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University Of California - San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
ተሳታዮችን በመፈለግ ላይደረጃ 3
- UC San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of California San Diego (UCSD) - Koman Family Outpatient Pavilion ? La Jolla, La Jolla · 11 ማይል ርቀት
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Scripps Health, San Diego
A Phase 1/1b Study of IAM1363 in HER2 Cancers
ተሳታዮችን በመፈለግ ላይደረጃ 1
- UCSD Moores Cancer Center, La Jolla · 11 ማይል ርቀት
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of California San Diego Medical Center, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 ማይል ርቀት
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of California-San Diego, La Jolla · 11 ማይል ርቀት
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Scripps Health, La Jolla · 11 ማይል ርቀት
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
ተሳታዮችን በመፈለግ ላይደረጃ 3
- UC San Diego, San Diego
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- UC San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- University of California, San Diego, San Diego
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Kaiser Permanente-Rio San Diego, San Diego
- Kaiser Permanente-San Diego Zion, San Diego
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
ተሳታዮችን በመፈለግ ላይጤናማ ተሳታዮች ይቀበላሉ
- University of California, San Diego, La Jolla · 11 ማይል ርቀት
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- UC San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
ተሳታዮችን በመፈለግ ላይደረጃ 2
- Scripps Health, San Diego
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
ተሳታዮችን በመፈለግ ላይደረጃ 3
- UC San Diego Medical Center - Hillcrest, San Diego
- California Protons Cancer Therapy Center, San Diego
- UC San Diego Moores Cancer Center, La Jolla · 11 ማይል ርቀት
FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of California, San Diego, La Jolla · 11 ማይል ርቀት
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
ተሳታዮችን በመፈለግ ላይደረጃ 3
- University of California San Diego - Moores Cancer Center, La Jolla · 11 ማይል ርቀት
E-Mindfulness Approaches for Living After Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 3
- Kaiser Permanente-San Diego Zion, San Diego
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- University of California, San Diego; Moores Cancer Center, San Diego
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1
- Investigative Site #101, La Jolla · 11 ማይል ርቀት
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of California San Diego, La Jolla · 11 ማይል ርቀት
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- SHARP Healthcare, San Diego
Artificial Intelligence and Machine Learning to Guide CDK4/6 Inhibitor Rechallenge in Breast Cancer.
ተሳታዮችን በመፈለግ ላይደረጃ 2
- University of California, San Diego, La Jolla · 11 ማይል ርቀት
A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
- Research Site, La Jolla · 11 ማይል ርቀት
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
ተሳታዮችን በመፈለግ ላይ
- UC San Diego Health, La Jolla · 11 ማይል ርቀት
Efficacy of OneMark Device in Identifying Breast Cancer for Surgery and Surveillance
ተሳታዮችን በመፈለግ ላይ
- University of California, San Diego, La Jolla · 11 ማይል ርቀት
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
- Massive Bio SYNERGY-AI site, La Jolla · 11 ማይል ርቀት
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
ተሳታዮችን በመፈለግ ላይደረጃ 1
- University of California-San Diego, San Diego
በሌሎች ከተሞች ለየጡንቻ ካንሰር የሚደረጉ ጥናቶች
- New York City, NY136 ጥናቶች
- Houston, TX126 ጥናቶች
- Boston, MA112 ጥናቶች
- Nashville, TN81 ጥናቶች
- Los Angeles, CA73 ጥናቶች
- Edison, NJ68 ጥናቶች
- St. Louis, MO64 ጥናቶች
- Queens, NY64 ጥናቶች
- Durham, NC64 ጥናቶች
- Chicago, IL59 ጥናቶች
- Philadelphia, PA56 ጥናቶች
- Dallas, TX55 ጥናቶች
በSan Diego ውስጥ ያሉ ሌሎች ጥናቶች
- ኖን-ስማል ሴል የሳንባ ካንሰር48 ጥናቶች
- ካንሰር (ሁሉም ዓይነቶች)32 ጥናቶች
- የፕሮስቴት ካንሰር31 ጥናቶች
- Metastatic Cancer30 ጥናቶች
- የኮሎሬክታል ካንሰር25 ጥናቶች
- የእንቁላል ካንሰር24 ጥናቶች
- የፓንክሪያስ ካንሰር24 ጥናቶች
- የሳንባ ካንሰር23 ጥናቶች
- ከባድ ሰውነት23 ጥናቶች
- የልብ ድካም23 ጥናቶች
- ዲፕሬሽን21 ጥናቶች
- ሜላኖማ18 ጥናቶች
ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።